MOFs Modulate Copper Trafficking in Tumor Cells for Bioorthogonal Therapy-Reference-Cited by-同舟云学术

MOFs Modulate Copper Trafficking in Tumor Cells for Bioorthogonal Therapy

Published:2024-01-22 Issue:4 Volume:24 Page:1341-1350
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Wei Yue¹²,Zhao Huisi¹²,Liu Zhenqi¹²,Yang Jie¹²,Ren Jinsong¹²^ORCID,Qu Xiaogang¹²^ORCID

Affiliation:

1. Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China

2. School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui 230026, P. R. China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Jilin Innovation Project

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.nanolett.3c04369

Reference61 articles.

1. Bioorthogonal catalytic patch

2. Cellular Incorporation of Unnatural Amino Acids and Bioorthogonal Labeling of Proteins

3. Development and application of bond cleavage reactions in bioorthogonal chemistry

4. Supramolecular regulation of bioorthogonal catalysis in cells using nanoparticle-embedded transition metal catalysts

5. A bioorthogonal system reveals antitumour immune function of pyroptosis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metal-organic frameworks derived emerging theranostic platforms;Nano Today;2024-10

2. Designing intelligent bioorthogonal nanozymes: Recent advances of stimuli-responsive catalytic systems for biomedical applications;Journal of Controlled Release;2024-09

3. Tumor Acidity‐Triggered Bioorthogonal Reactions for Biomedical Applications;ChemBioChem;2024-08-19

4. Smart Bioorthogonal Nanozymes: From Rational Design to Appropriate Bioapplications;Advanced Materials;2024-08-16

5. Adaptive Size Evolution of an MOFs-in-MOF Nanovehicle for Enhanced Nucleus-Targeted Tumor Chemotherapy;Nano Letters;2024-08-15